DGX
Quest Diagnostics Incorporated
$184.69
+$1.09(+0.59%)
72
Overall
100
Value
45
Tech
--
Quality
Market Cap
$20.15B
Volume
975.96K
52W Range
$146.17 - $185.62
Target Price
$188.71
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $7.5B | $7.5B | $7.4B | $7.5B | $7.7B | $9.4B | $10.8B | $9.9B | $9.3B | $9.9B | ||
| Total Revenue | $7.5B | $7.5B | $7.4B | $7.5B | $7.7B | $9.4B | $10.8B | $9.9B | $9.3B | $9.9B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $4.7B | $4.6B | $4.7B | $4.9B | $5.0B | $5.8B | $6.6B | $6.5B | $6.2B | $6.6B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $2.8B | $2.9B | $2.7B | $2.6B | $2.7B | $3.6B | $4.2B | $3.4B | $3.1B | $3.2B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $1.8B | $6.4B | $6.2B | $6.4B | $6.5B | $1.7B | $8.4B | $2.0B | $1.8B | $1.9B | ||
| Research & Development | -- | -- | -- | -- | -- | -- | $6.6B | -- | -- | -- | ||
| Selling, General & Administrative | $1.7B | $1.7B | $6.2B | $6.3B | $6.5B | $1.6B | $8.3B | $1.9B | $1.6B | $1.8B | ||
| Selling & Marketing Expenses | -- | -- | $4.7B | -- | $5.0B | $38.0M | $6.6B | $74.0M | $31.0M | $28.0M | ||
| General & Administrative Expenses | $1.7B | $1.7B | $1.4B | $6.3B | $1.5B | $1.6B | $1.7B | $1.9B | $1.6B | $1.8B | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | $38.0M | $78.0M | -- | -- | -- | ||
| Salaries & Wages | $52.0M | $-32.0M | $-67.0M | $-33.0M | $-27.0M | $-39.0M | $-32.0M | -- | -- | -- | ||
| Depreciation & Amortization | $81.0M | $4.7B | $74.0M | $90.0M | $96.0M | $103.0M | $103.0M | $120.0M | $108.0M | $127.0M | ||
| Depreciation & Amortization | $81.0M | $4.7B | $74.0M | $90.0M | $96.0M | $103.0M | $103.0M | $120.0M | $108.0M | $127.0M | ||
| Amortization | $81.0M | $4.7B | $74.0M | $90.0M | $96.0M | $103.0M | $103.0M | $120.0M | $108.0M | $127.0M | ||
| Other Operating Expenses | $11.0M | $-13.0M | $1.0M | $-10.0M | $-95.0M | $9.0M | $-2.0M | $11.0M | $41.0M | $1.0M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $1.4B | $1.3B | $1.2B | $1.1B | $1.2B | $2.0B | $2.4B | $1.4B | $1.3B | $1.3B | ||
| EBITDA | $1.6B | $1.5B | $1.5B | $1.4B | $1.6B | $2.4B | $3.2B | $1.9B | $1.6B | $1.7B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $153.0M | $143.0M | $151.0M | $167.0M | $175.0M | $166.0M | $152.0M | $148.0M | $163.0M | -- | ||
| Interest Income Operating | $1.0M | $1.0M | $2.0M | $2.0M | $5.0M | $3.0M | $1.0M | $10.0M | $11.0M | $25.0M | ||
| Intinc | -- | -- | -- | -- | -- | -- | -- | -- | $-152.0M | $-201.0M | ||
| Net Non-Operating Interest Income/Expense | $-153.0M | $-143.0M | $-151.0M | $-167.0M | $-175.0M | $-163.0M | $-151.0M | $-138.0M | $-152.0M | $-201.0M | ||
| Gain on Sale of Securities | -- | $3.0M | $8.0M | $-2.0M | $10.0M | $8.0M | $56.0M | -- | -- | -- | ||
| Other Income/Expense | $-214.0M | $-109.0M | $-51.0M | $-36.0M | $-77.0M | $-151.0M | $-447.0M | $-55.0M | $-46.0M | $-49.0M | ||
| Other Special Charges | $-143.0M | $-48.0M | $16.0M | $-8.0M | $20.0M | $76.0M | $369.0M | $-55.0M | $20.0M | $30.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $39.0M | $11.0M | $30.0M | $49.0M | $-3.0M | $14.0M | $13.0M | -- | -- | -- | ||
| Special Income Charges | $-39.0M | $-11.0M | $-30.0M | $-49.0M | $3.0M | $-14.0M | $-13.0M | $-55.0M | $842.0M | $869.0M | ||
| Impairment of Capital Assets | $16.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $1.3B | $1.2B | $1.2B | $1.1B | $1.3B | $2.0B | $2.8B | $1.4B | $1.2B | $1.2B | ||
| Pre-Tax Income | $1.1B | $1.1B | $1.0B | $926.0M | $1.1B | $1.9B | $2.6B | $1.2B | $1.1B | $1.2B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $373.0M | $429.0M | $241.0M | $182.0M | $247.0M | $460.0M | $597.0M | $264.0M | $248.0M | $273.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $709.0M | $645.0M | $772.0M | $736.0M | $858.0M | $1.4B | $2.0B | $946.0M | $854.0M | $871.0M | ||
| Net Income (Continuing Operations) | $709.0M | $645.0M | $772.0M | $736.0M | $858.0M | $1.4B | $2.0B | $1.0B | $908.0M | $921.0M | ||
| Net Income (Discontinued Operations) | $709.0M | $645.0M | $772.0M | $736.0M | $858.0M | $1.4B | $2.0B | $946.0M | $854.0M | $871.0M | ||
| Net Income (Common Stockholders) | $709.0M | $645.0M | $772.0M | $736.0M | $858.0M | $1.4B | $2.0B | $942.0M | $854.0M | $871.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $6.4B | $11.0B | $11.0B | $11.4B | $11.5B | $7.5B | $15.0B | $8.5B | $8.0B | $8.5B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $144.0M | $140.0M | $137.0M | $136.0M | $134.0M | $134.0M | $125.0M | $116.0M | $112.0M | $111.0M | ||
| Average Shares Outstanding (Diluted) | $145.0M | $142.0M | $140.0M | $139.0M | $136.0M | $136.0M | $128.0M | $118.0M | $113.0M | $113.0M | ||
| Shares Outstanding | $142.8M | $137.5M | $135.6M | $134.3M | $133.5M | $133.5M | $119.5M | $111.3M | $110.7M | $111.0M | ||
| Basic EPS | $4.92 | $4.58 | $5.63 | $5.39 | $6.36 | $10.62 | $15.85 | $8.1 | $7.59 | $7.78 | ||
| Basic EPS (Continuing Operations) | $4.92 | $4.58 | $5.63 | $5.39 | $6.21 | $10.62 | $15.85 | $8.1 | $7.59 | $7.78 | ||
| Diluted EPS | $4.87 | $4.51 | $5.5 | $5.29 | $6.28 | $10.47 | $15.55 | $7.97 | $7.49 | $7.69 | ||
| Diluted EPS (Continuing Operations) | $4.87 | $4.51 | $5.5 | $5.29 | $6.13 | $10.47 | $15.55 | $7.97 | $7.49 | $7.69 | ||
| Dividend Per Share | $1.52 | $1.65 | $1.8 | -- | -- | -- | -- | $2.6 | $2.79 | -- | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | $4.9B | -- | -- | -- | -- | -- | -- | ||
| Allowances For Construction | -- | -- | -- | -- | -- | $5.8B | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | -- | -- | -- | $0.15 | -- | -- | -- | -- | -- | ||
| Commission Expenses | -- | -- | -- | -- | $5.0B | -- | -- | -- | -- | -- | ||
| Development Expense | -- | -- | -- | -- | -- | -- | $6.6B | -- | -- | -- | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | $0.15 | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $23.0M | $39.0M | $35.0M | $44.0M | $57.0M | $75.0M | $78.0M | $44.0M | $26.0M | $19.0M | ||
| Earnings From Equity Interest Net Of Tax | $23.0M | $39.0M | $35.0M | $44.0M | $57.0M | $75.0M | $78.0M | $44.0M | $26.0M | $19.0M | ||
| Gain On Sale Of Business | $334.0M | $118.0M | -- | $-4.0M | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | -- | $-201.0M | $-159.0M | -- | -- | -- | ||
| Marketing Expense | -- | -- | -- | -- | -- | -- | $6.6B | -- | -- | -- | ||
| Minority Interests | $-44.0M | $-51.0M | $-52.0M | $-52.0M | $-48.0M | $-68.0M | $-85.0M | $-69.0M | $-54.0M | $-50.0M | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | $20.0M | -- | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | $20.0M | -- | -- | -- | -- | -- | ||
| Other Gand A | $1.7B | $1.7B | $1.4B | $6.3B | $1.5B | $1.6B | $1.7B | $1.9B | $1.6B | $1.8B | ||
| Other Impairment Of Capital Assets | $16.0M | $7.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Taxes | $4.7B | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | $6.0M | $1.0M | -- | -- | -- | ||
| Rent And Landing Fees | $224.0M | $216.0M | $219.0M | $4.9B | -- | -- | -- | -- | -- | -- | ||
| Restruct | $39.0M | $11.0M | $30.0M | $49.0M | $-3.0M | $14.0M | $13.0M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DGX | $184.69 | +0.6% | 975.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Quest Diagnostics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW